טוען...
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma
BACKGROUND: Accurate prediction of the prognosis of RCC using a single biomarker is challenging due to the genetic heterogeneity of the disease. However, it is essential to develop an accurate system to allow better patient selection for optimal treatment strategies. ARL4C, ECT2, SOD2, and STEAP3 ar...
שמור ב:
| הוצא לאור ב: | World J Surg Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7584101/ https://ncbi.nlm.nih.gov/pubmed/33092599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-02046-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|